These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34068040)

  • 1. ELTD1-An Emerging Silent Actor in Cancer Drama Play.
    Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker.
    Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A
    Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
    Niinivirta M; Georganaki M; Enblad G; Lindskog C; Dimberg A; Ullenhag GJ
    BMC Cancer; 2020 Apr; 20(1):339. PubMed ID: 32321460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer.
    Sun J; Zhang Z; Chen J; Xue M; Pan X
    Int J Biol Sci; 2021; 17(12):3048-3058. PubMed ID: 34421349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of ELTD1, a pro-angiogenic adhesion GPCR.
    Favara DM; Banham AH; Harris AL
    Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis.
    Li J; Shen J; Wang Z; Xu H; Wang Q; Chai S; Fu P; Huang T; Anas O; Zhao H; Li J; Xiong N
    Sci Rep; 2019 Sep; 9(1):13904. PubMed ID: 31554859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELTD1, a potential new biomarker for gliomas.
    Towner RA; Jensen RL; Colman H; Vaillant B; Smith N; Casteel R; Saunders D; Gillespie DL; Silasi-Mansat R; Lupu F; Giles CB; Wren JD
    Neurosurgery; 2013 Jan; 72(1):77-90; discussion 91. PubMed ID: 23096411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis.
    Masiero M; Simões FC; Han HD; Snell C; Peterkin T; Bridges E; Mangala LS; Wu SY; Pradeep S; Li D; Han C; Dalton H; Lopez-Berestein G; Tuynman JB; Mortensen N; Li JL; Patient R; Sood AK; Banham AH; Harris AL; Buffa FM
    Cancer Cell; 2013 Aug; 24(2):229-41. PubMed ID: 23871637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) via siRNA-induced cell death in glioblastoma.
    Serban F; Daianu O; Tataranu LG; Artene SA; Emami G; Georgescu AM; Alexandru O; Purcaru SO; Tache DE; Danciulescu MM; Sfredel V; Dricu A
    J Immunoassay Immunochem; 2017; 38(1):21-33. PubMed ID: 27379831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK.
    Sun B; Zhong FJ
    Int J Gen Med; 2021; 14():4897-4911. PubMed ID: 34475781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system.
    Luo Q; Wei C; Long Y; Zhang M; Shan W; Li H; Cai S; Xu Y; Qian P; Huang H
    Stem Cell Res; 2021 May; 53():102350. PubMed ID: 34087984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.
    Ziegler J; Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Patel M; Wren JD; Lupu F; Battiste J; Towner RA
    Am J Nucl Med Mol Imaging; 2019; 9(1):93-109. PubMed ID: 30911439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent.
    Kan A; Le Y; Zhang YF; Duan FT; Zhong XP; Lu LH; Ling YH; Guo RP
    J Cancer; 2018; 9(14):2415-2427. PubMed ID: 30026838
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling.
    Favara DM; Liebscher I; Jazayeri A; Nambiar M; Sheldon H; Banham AH; Harris AL
    Sci Rep; 2021 Apr; 11(1):8870. PubMed ID: 33893326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.
    Zalles M; Smith N; Saunders D; Guzman M; Lerner M; Fung KM; Babu A; Battiste J; Chung J; Hwang K; Jin J; Towner RA
    Neurooncol Adv; 2021; 3(1):vdab132. PubMed ID: 34704036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPRC5A: An Emerging Biomarker in Human Cancer.
    Jiang X; Xu X; Wu M; Guan Z; Su X; Chen S; Wang H; Teng L
    Biomed Res Int; 2018; 2018():1823726. PubMed ID: 30417009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression.
    Sheldon H; Bridges E; Silva I; Masiero M; Favara DM; Wang D; Leek R; Snell C; Roxanis I; Kreuzer M; Gileadi U; Buffa FM; Banham A; Harris AL
    Mol Cancer Res; 2021 Nov; 19(11):1957-1969. PubMed ID: 34348993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants.
    Favara DM; Banham AH; Harris AL
    BMC Evol Biol; 2019 Jul; 19(1):143. PubMed ID: 31299890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCRs and cancer.
    Lappano R; Maggiolini M
    Acta Pharmacol Sin; 2012 Mar; 33(3):351-62. PubMed ID: 22266725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model.
    Zalles M; Smith N; Saunders D; Saran T; Thomas L; Gulej R; Lerner M; Fung KM; Chung J; Hwang K; Jin J; Battiste J; Towner RA
    Transl Oncol; 2020 Mar; 13(3):100737. PubMed ID: 32208341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.